Most recently, it's been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar locations as classical opioid receptors, it binds into a big selection of endogenous opioids. Compared with most opioid receptors, this receptor functions being a scavenger and will no… Read More